Dr. Joji J. Varghese, MD

Dr. Varghese practices at Heart360 Specialists in Birmingham, Alabama.

Dr. Varghese's NPI, 1053479683, was assigned on December 5, 2006. Dr. Varghese graduated from TD Medical College Kerala in 2000. Dr. Varghese holds Texas license N1202.

Dr. Varghese's primary practice is Heart360 Specialists, at 117 Gemini Cir, Birmingham, AL 35209 in Jefferson County. The practice phone is (817) 803-1234.

Dr. Varghese's primary practice is Heart360 Specialists in Birmingham, Alabama. Dr. Varghese is also affiliated with Hendrick Medical Center. The medical group on file is Hendrick Provider Network. Dmand AI also links Dr. Varghese to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varghese practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Varghese's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Varghese is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Varghese's licenses on file in 4 states: Texas, Oklahoma, Illinois and Arkansas.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Varghese treats.

CMS data shows 2,462 Medicare services from Dr. Varghese across 36 procedure codes in 2024, for 1,193 Medicare patients. Medicare paid $164,821 for them.

CMS counts 1,193 Medicare patients who saw Dr. Varghese in 2024. The largest group is 65 to 74, with 491 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Varghese's median patient age at 75, with 47% women.

In 2024, Dr. Varghese wrote 5,996 Medicare Part D claims for 881 patients. 78% of them were for generic drugs. CMS names the drug for 5,716 of them, across 50 drugs with 11 or more claims each, at $1,179,244 in total drug cost. In 2023, CMS named 6,624 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Varghese for performance year 2024, reported as part of a group. Dr. Varghese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Varghese as offering telehealth. CMS counts 31 procedures of coronary angioplasty and stenting by Dr. Varghese, more than 67% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Varghese, published from 2006 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Comorbidity, Angioplasty, Balloon, Coronary and Arthritis, Rheumatoid. Dr. Varghese has published most often in J Invasive Cardiol. Dr. Varghese's most frequent co-authors are Sushma Koneru, MD, Srihari S. Naidu, MD and Frank V. Aguirre, MD.

CMS Open Payments shows 1,058 general payments to Dr. Varghese from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Abbott Laboratories paid the most, $14,603.

Dmand AI lists 2 awards for Dr. Varghese, most recently CMS Stage 1 EHR in 2013.

Dr. Varghese graduated from TD Medical College Kerala in 2000. Dr. Varghese is a member of ACC.

Dr. Varghese is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.